HKU Pharmacy HKU Medicine

Following S-ketamine, Psilocybin is potential to become the next medication for treatment-resistant depression. Current clinical trials showed significant efficacy with acceptable safety performance.
authors.elsevier.com/c/1j7yCbZg7P~IK

proud of my students, Yaming & Shuting @HKUPharm @HKUMed, who won 2 gold and 1 silver award at the 49th International Exhibition of Inventions Geneva!

Our work ⁦BMC Medicine⁩ found 21% of depression incidence increasing during the pandemic but 11-16% less health service used compared with pre-pandemics. The system is recovering with service rebound over 3 years.⁦HKU Pharmacy⁩ ⁦Prof Ian Wong⁩ link.springer.com/article/10.118…

New Review📖
' #Ce6 nanoassemblies: Molecular mechanism and strategies for combinational anticancer therapy' by Weiping Wang et al. Weiping Wang HKU Pharmacy HKU Medicine Wiley Biomedical Science #CancerResearch #nanomedicine #PDT #SelfAssembly

Check👉doi.org/10.1002/agt2.4…

Our Lead Scientist Prof Ian Wong and his team published a paper on the Nature Medicine, sharing their new findings which suggest no direct causal relationship between #gestational diabetes and #ADHD .

Laboratory of Data Discovery for Health HKU Medicine HKU Pharmacy

I think it's Franco WT Cheng who's meant to be tagged! Congrats Franco for this excellent work! :) HKU Medicine HKU Pharmacy The University of Hong Kong

Our study involving 3.6m mother-child pairs in
Nature Medicine suggests no direct causal relationship between gestational diabetes and ADHD. Instead, it highlights the importance of considering a holistic risk profile like shared genetic/familial factors.
nature.com/articles/s4159…

Wonderful to have a representative Claire Cuiling WEI of my team HKU Pharmacy to present our work at #BJGPconference which highlights the importance of primary care post-covid 😎 The British Journal of General Practice Well done and looking forward to seeing it published!

This is me waiting to teach my last session of #BPharm Y1 research methods class; of note, The University of Hong Kong and HKU Pharmacy arranged a lecture theatre with 400+ seats for my class of 34 students, much appreciated 😝

Our Lead Scientist Prof Ian Wong & his team published a paper in the Endocrine Practice, sharing their latest evaluation on the risk of incident #thyroid #dysfunction in the post-acute phase of #COVID19 .

doi.org/10.1016/j.epra…

Laboratory of Data Discovery for Health HKU Medicine HKU Pharmacy

P-CARDIAC secondary model's paper is finally out! A 10-year CVD risk prediction model for Chinese with established CVD risk. Go check out the article available on European Society of Cardiology European Society of Cardiology Journals #EHJDigitalHealth #P_CARDIAC HKU Medicine HKU Nursing HKU Pharmacy

doi.org/10.1093/ehjdh/…

🔍 Our new study reveals promising findings for CKD patients with COVID-19. Molnupiravir and nirmatrelvir-ritonavir may reduce mortality rates. Dive into the research conducted in Hong Kong for an in-depth understanding. 🏥💊 Read more here: kireports.org/article/S2468-…

Eric YF Wan Vincent Yan Prof Ian Wong Esther Chan @ CSMPR HKU Sydney Tang Also, appreciating the invaluable contributions of PIs Francisco TT Lai, Celine Chui HKU, Carlos KH Wong & Shirley Xue Li
HKU Pharmacy

Our lead scientist Prof Ian Wong & his team published a paper in The Journal of Bone and Mineral Research, sharing that older individuals with COVID-19 infection are at a higher risk of suffering from major #osteoporotic #fractures than those not infected.
academic.oup.com/jbmr/advance-a…
Laboratory of Data Discovery for Health @hkupharm @HKUMed

Our first attempt of using GPT for medical literature review through Faculty Research Collaboration Data Task Force. ⁦Prof Ian Wong⁩ ⁦Esther Chan @ CSMPR HKU⁩ ⁦HKU Medicine⁩⁦HKU Pharmacy⁩ medrxiv.org/content/10.110…

Our recent study using CDM on Cambridge Core finds immediate declines in mental health diagnoses following population-wide COVID-19 restrictions in France, Germany, Italy, UK, and US. doi.org/10.1017/S20457…
#COVID19
#mentalillness
Prof Ian Wong Kenneth Man Wallis Lau Hao Luo

Congratulations to Laboratory of Data Discovery for Health's research members for their outstanding publications, recognised with the “Faculty Outstanding Research Output Awards 2023” at HKU Medicine!
HKU Public Health HKU Pharmacy

Researchers from HKU Pharmacy have developed a neutralising monoclonal antibody, 6H2, which targets a harmful protein known to exacerbate the damage caused by ischaemic stroke.

For more on their findings: hkumed.hk/327

Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in patients with #COVID19

Nirmatrelvir-ritonavir was more effective than molnupiravir in reducing risk of all-cause mortality

Eric YF Wan Vincent Yan Prof Ian Wong Esther Chan @ CSMPR HKU

thelancet.com/journals/eclin…